Economic evaluation of prenatal screening for Down syndrome in the U.S.A.

This publication has 16 references indexed in Scilit:

• Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies
  Prenatal Diagnosis, 1998
• The effect of differences in the distribution of maternal age in England and Wales on the performance of prenatal screening for Down's syndrome
  Prenatal Diagnosis, 1997
• Maternal serum screening for Down syndrome in the United States: A 1995 survey
  American Journal of Obstetrics and Gynecology, 1997
• Down syndrome and neural tube defect screening: The value of using gestational age by ultrasonography
  American Journal of Obstetrics and Gynecology, 1997
• Prenatal diagnosis of diverse chromosome abnormalities in a population of patients identified by triple-marker testing as screen positive for Down syndrome
  American Journal of Obstetrics and Gynecology, 1995
• Advent of Maternal Serum Markers for Down Syndrome Screening
  Obstetrical & Gynecological Survey, 1995
• Second‐trimester maternal serum screening using alpha‐fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol: Experience of a regional programme
  Prenatal Diagnosis, 1994
• Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha‐fetoprotein level
  BJOG: An International Journal of Obstetrics and Gynaecology, 1987
• An economic appraisal of screening for Down's syndrome in pregnancy using maternal age and serum alpha fetoprotein concentration
  Social Science & Medicine, 1987
• Maternal age specific rates for chromosome aberrations and factors influencing them: Report of a collaborative european study on 52 965 amniocenteses
  Prenatal Diagnosis, 1984